Special issues
Browse all special issues from Journal of Biopharmaceutical Statistics.
All issues
- Special issues
Special Issue on Statistics in Pediatric Drug Development
Volume 33, Issue 6, 2023 pages 677-v
Special issue of Estimand
Volume 33, Issue 4, 2023 pages 401-513
Special issue on Emerging Clinical Initiatives in Pharmaceutical Development: Methodology and Regulatory Perspectives
Volume 32, Issue 3, 2022 pages 357-526
Special Issue on Real World Evidence
Volume 32, Issue 1, 2022 pages 1-218
Innovative Design and Analysis of Complex Clinical Trials
Volume 30, Issue 6, 2020 pages 947-vii
Special Issue of 2018 FDA Statistical Conference - Meet the Challenges in Regulatory Science
Volume 29, Issue 5, 2019 pages 731-970
Special Issue: Real Word Experience and Randomized Clinical Trials
Volume 29, Issue 4, 2019 pages 579-729
Special Issue: Precision Medicine in Cancer Research
Volume 28, Issue 2, 2018 pages 215-383
Special issue: Multiplicity issues in clinical trials
Volume 28, Issue 1, 2018 pages 1-214
Special Issue dedicated to 2016 Trends and Innovations in Clinical Trial Statistics (TICTS) Conference
Volume 27, Issue 3, 2017 pages 357-569
Special Issue on Biosimilarity Assessment, Guest Edited by Victoria Yu-Wei Chang and Laszlo Endrenyi
Volume 27, Issue 2, 2017 pages 195-355
In Honor of Dr. Greg Campbell's Retirement
Volume 26, Issue 6, 2016 pages 1007-1150
Trends and innovations in clinical trial statistics
Volume 26, Issue 1, 2016 pages 1-190
Recent Developments in Statistical Approaches for Chemistry and Manufacturing Control (CMC) and Quality-by-Design (QbD)
Volume 25, Issue 2, 2015 pages 233-371
Issues in Biosimilar Drug Development
Volume 24, Issue 6, 2014 pages 1137-ebi
The 2013 ASA Biopharmaceutical FDA/Industry Statistics Workshop
Volume 24, Issue 5, 2014 pages 965-1136
Subgroup Analysis in Clinical Trials
Volume 24, Issue 1, 2014 pages 1-210
Medical Product Safety
Volume 23, Issue 1, 2013 pages 1-279
Bridging and Multiregional Clinical Trials
Volume 22, Issue 5, 2012 pages 875-1096
Adaptive Designs for Clinical Trials: Considerations about and Beyond the FDA Adaptive Designs Guidance
Volume 22, Issue 4, 2012 pages 615-873
Special Issue on Computer-Intensive Methods with Emphasis on Bootstrap and Medical Research Applications
Volume 21, Issue 6, 2011 pages 1049-ebi
Bayesian Approaches for Medical Product Evaluation
Volume 21, Issue 5, 2011 pages 869-1048
Dealing with Multiplicity in Drug Development: Current State and New Directions
Volume 21, Issue 4, 2011 pages 581-867
Missing Data – Principal, Theory and Applications
Volume 21, Issue 2, 2011 pages 177-370
Special Theme for Adaptive Clinical Trial Designs
Volume 20, Issue 6, 2010 pages 1083-1226
Continued Discussion in Design and Analysis of Thorough QTc Studies
Volume 20, Issue 3, 2010 pages 493-704
Statistical Genomics in Clinical Trials
Volume 20, Issue 2, 2010 pages 191-491
Follow-on Biologics
Volume 20, Issue 1, 2009 pages 1-190
Missing Data – Prevention and Analysis
Volume 19, Issue 6, 2009 pages 941-1171